201 GENES FOUNDi
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
RNA tissue categoryi x
PRKAA1Protein kinase AMP-activated catalytic subunit alpha 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nuclear specklesExpressed in all
PRKAB1Protein kinase AMP-activated non-catalytic subunit beta 1FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
PSMB1Proteasome subunit beta 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
PSMB10Proteasome subunit beta 10Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
PSMB2Proteasome subunit beta 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleoplasmExpressed in all
PSMB5Proteasome subunit beta 5Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Centrosome
Expressed in all
PSMB8Proteasome subunit beta 8Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytokinetic bridge
Mixed
PSMB9Proteasome subunit beta 9Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolMixed
RAF1Raf-1 proto-oncogene, serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nuclear specklesExpressed in all
RARARetinoic acid receptor alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleus
Cytosol
Expressed in all
RARBRetinoic acid receptor betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleoplasmMixed
RARGRetinoic acid receptor gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmTissue enhanced
RFKRiboflavin kinaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusExpressed in all
RPL3Ribosomal protein L3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Ribosomal proteins
Nucleoli
Cytosol
Expressed in all
RRM1Ribonucleotide reductase catalytic subunit M1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
RXRARetinoid X receptor alphaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nucleus
Golgi apparatus
Mixed
RXRBRetinoid X receptor betaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleusMixed
RXRGRetinoid X receptor gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Tissue enhanced
SHMT1Serine hydroxymethyltransferase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Expressed in all
SIRT5Sirtuin 5FDA approved drug targets
Predicted intracellular proteins
MitochondriaExpressed in all
SMOXSpermine oxidaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Nuclear membrane
Vesicles
Tissue enhanced
SMSSpermine synthaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nuclear bodies
Cytosol
Expressed in all
SNAP25Synaptosome associated protein 25Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SRCSRC proto-oncogene, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Mixed
THTyrosine hydroxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enriched
THRAThyroid hormone receptor, alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
CytosolExpressed in all
THRBThyroid hormone receptor betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nuclear bodiesMixed
TNFTumor necrosis factorCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
TNNC1Troponin C1, slow skeletal and cardiac typeDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Actin filaments
Mitochondria
Group enriched
TOP1Topoisomerase (DNA) ICancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Expressed in all
TOP1MTTopoisomerase (DNA) I, mitochondrialEnzymes
FDA approved drug targets
Predicted intracellular proteins
MitochondriaExpressed in all
TOP2ATopoisomerase (DNA) II alphaCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli
Tissue enhanced
TOP2BTopoisomerase (DNA) II betaEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
TPH1Tryptophan hydroxylase 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
CytosolGroup enriched
TPH2Tryptophan hydroxylase 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
TPK1Thiamin pyrophosphokinase 1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
VesiclesMixed
TPMTThiopurine S-methyltransferaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
TUBA1ATubulin alpha 1aCancer-related genes
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
MicrotubulesExpressed in all
TUBA4ATubulin alpha 4aDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MicrotubulesExpressed in all
TUBBTubulin beta class IDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MicrotubulesExpressed in all
TUBB1Tubulin beta 1 class VIDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
TUBB3Tubulin beta 3 class IIIDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
TUBB4BTubulin beta 4B class IVbFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MicrotubulesExpressed in all
TUBD1Tubulin delta 1FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
TUBE1Tubulin epsilon 1FDA approved drug targets
Predicted intracellular proteins
Expressed in all
TUBG1Tubulin gamma 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
TXNRD1Thioredoxin reductase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
TYMSThymidylate synthetaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Mixed
VDRVitamin D (1,25- dihydroxyvitamin D3) receptorDisease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Transporters
NucleoplasmTissue enhanced
XDHXanthine dehydrogenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusTissue enhanced
« prev | Page of 5 | next »